Cohen David B, Rinker Charles, Wilberger Jack E
Department of Neurosurgery, Allegheny General Hospital, Pittsburgh, Pennsylvania 15212, USA.
J Trauma. 2006 Mar;60(3):553-7. doi: 10.1097/01.ta.0000196542.54344.05.
Coumadin is widely used in the elderly population. Despite its widespread use, little is known about its effect on the outcome of elderly traumatic brain-injured patients. This study was undertaken to describe the outcomes of such a cohort.
Clinical material was identified from a Level I trauma center prospective head injury database, and a database obtained from the American College of Surgeons Committee on Trauma Verification and Review Committee from 1999 to 2002. Both databases contain many relevant variables, including age, sex, Glasgow Coma Scale (GCS) score, mechanism of injury, Injury Severity Score, International Normalized Ratio (INR), computed tomography (CT) findings, operative procedure, time to operating room, complications, length of stay, and outcome at hospital discharge.
For patients with GCS scores less than 8, average INR was 6.0, with almost 50% having an initial value greater than 5.0. Overall mortality was 91.5%. For the 77 patients with GCS scores of 13 to 15, average INR was 4.4. Overall mortality for this group was 80.6%. A subset of patients deteriorated to a GCS score of less than 10 just hours after injury, despite most having normal initial CT scans. Mortality in this group was 84%.
All patients on warfarin should have an INR performed, and a CT scan should be done in most anticoagulated patients. All supratherapeutically anticoagulated patients, as well as any anticoagulated patient with a traumatic CT abnormality, should be admitted for neurologic observation and consideration given to short term reversal of anticoagulation. Routine repeat CT scanning at 12 to 18 hours or when even subtle signs of neurologic worsening occur is a strong recommendation. A multi-institutional, prospective trial using these guidelines would be a first step toward demonstrating improved outcomes in the anticoagulated patient population after head trauma.
华法林在老年人群中广泛使用。尽管其使用广泛,但对于其对老年创伤性脑损伤患者预后的影响却知之甚少。本研究旨在描述此类患者队列的预后情况。
临床资料来自一级创伤中心前瞻性头部损伤数据库,以及1999年至2002年从美国外科医师学会创伤验证与审查委员会获得的数据库。两个数据库都包含许多相关变量,包括年龄、性别、格拉斯哥昏迷量表(GCS)评分、损伤机制、损伤严重程度评分、国际标准化比值(INR)、计算机断层扫描(CT)结果、手术操作、进入手术室的时间、并发症、住院时间以及出院时的预后情况。
对于GCS评分低于8分的患者,平均INR为6.0,近50%的患者初始值大于5.0。总体死亡率为91.5%。对于77例GCS评分为13至15分的患者,平均INR为4.4。该组总体死亡率为80.6%。一部分患者在受伤后数小时内GCS评分恶化至低于10分,尽管大多数患者初始CT扫描正常。该组死亡率为84%。
所有服用华法林的患者都应检测INR,大多数抗凝患者应进行CT扫描。所有抗凝治疗超标的患者,以及任何有创伤性CT异常的抗凝患者,都应入院进行神经学观察,并考虑短期逆转抗凝。强烈建议在12至18小时或出现哪怕是轻微神经功能恶化迹象时进行常规重复CT扫描。采用这些指南进行多机构前瞻性试验将是朝着改善头部创伤后抗凝患者群体预后迈出的第一步。